硬质气管支气管镜不良事件的多中心回顾性分析
该多中心回顾性分析纳入2009至2015年8个中心的1546例硬质气管支气管镜(RTB)操作,非致死性并发症发生率为6.7%(95%CI: 5.5-8.0%),围术期死亡率为1.2%(95%CI: 0.6-1.8%),30天死亡率为5.6%(95%CI: 4.5-6.8%)。急诊操作并发症发生率进一步升高,恶性气道梗阻(MAO)患者30天死亡率高于良性气道狭窄(BAS)患者(8.1% vs 2.7%,P<0.01)。
要点
- RTB非致死性并发症发生率为6.7%,围术期死亡率为1.2%。
- RTB后30天死亡率为5.6%。
- 急诊操作并发症发生率更高,MAO患者30天死亡率高于BAS患者。
核心结论
- RTB与6.7%的非致死性并发症发生率、1.2%的围术期死亡率和5.6%的30天死亡率相关。
- 急诊操作并发症发生率进一步升高,MAO患者30天死亡率高于BAS患者。
研究设计与样本
- 多中心回顾性分析,纳入8个参与中心2009至2015年进行的RTB操作。
- 共分析1546例RTB操作。
主要发现
- 围术期死亡率为1.2%(95%CI: 0.6-1.8%),30天死亡率为5.6%(95%CI: 4.5-6.8%)。
- 急诊操作时并发症发生率进一步升高。
- MAO患者30天死亡率为8.1%,BAS患者为2.7%(P<0.01),且并发症谱不同。
临床怎么用
- 临床可参考上述并发症与死亡率数据评估RTB风险。
- 对急诊操作及MAO患者应更谨慎评估风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Rigid tracheobronchoscopy (RTB) has seen an increasing interest over the last decades with the development of the field of IPM but no benchmark exists for complication rates in RTB. We aimed to establish benchmarks for complication rates in RTB. METHODS: A multicentric retrospective analysis of RTB performed between 2009 and 2015 in eight participating centres was performed. RESULTS: A total of 1546 RTB were performed over the study period. One hundred and thirty-one non-lethal complications occurred in 103 procedures (6.7%, 95% CI: 5.5-8.0%). The periprocedural mortality rate was 1.2% (95% CI: 0.6-1.8%). The 30-day mortality rate was 5.6% (95% CI: 4.5-6.8%). Complication rate increases further when procedures were performed in an emergency setting. Procedures in patients with MAO are associated with a higher 30-day mortality (8.1% vs 2.7%, P < 0.01) and a different complication profile when compared to procedures performed for BAS. CONCLUSION: RTB is associated with a 6.7% non-lethal complication rate, a 1.2% periprocedural mortality rate and a 5.6% 30-day mortality in a large multicentre cohort of patients with benign and malignant airway disease.
引用
- Fortin M, Yarmus L, Rendina EA, et al. Multi-institutional retrospective analysis of adverse events following rigid tracheobronchoscopy. Respirology. 2020. PMID: 32537884. doi:10.1111/resp.13873
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。